CAS No.1260141-27-2 Fumarate Vonoprazan

Category
Name
CAS No.1260141-27-2 Fumarate Vonoprazan
Business
Category
Note
CAS No.1260141-27-2 Fumarate Vonoprazan
Vonoprazan Fumarate (TAK-438 CAS No.1260141-27-2), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+, K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan fumarate fda approval is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease.
Categories
Norway flag